Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. cell death & differentiation 
3. original paper 
4. article
Show authors
•  Original Paper
•  Published: 12 July 2013


The Hippo pathway kinase
Lats2 prevents DNA damage-
induced apoptosis through
inhibition of the tyrosine
kinase c-Abl
•  N Reuven1,
•  J Adler1,
•  V Meltser1 &
•  …
•  Y Shaul
1 
Cell Death & Differentiation volume 20, pages 1330–1340
(2013)Cite this article
•  6107 Accesses
•  66 Citations
•  Metrics details
Subjects
•  Apoptosis
•  DNA damage response
•  HIPPO signalling
Abstract
The Hippo pathway is an evolutionarily conserved pathway that
controls cell proliferation, organ size, tissue regeneration and stem
cell self-renewal. Here we show that it also regulates the DNA
damage response. At high cell density, when the Hippo pathway is
active, DNA damage-induced apoptosis and the activation of the


tyrosine kinase c-Abl were suppressed. At low cell density,
overexpression of the Hippo pathway kinase large tumor suppressor
2 (Lats2) inhibited c-Abl activity. This led to reduced
phosphorylation of downstream c-Abl substrates, the transcription
coactivator Yes-associated protein (Yap) and the tumor suppressor
p73. Inhibition of c-Abl by Lats2 was mediated through Lats2
interaction with and phosphorylation of c-Abl. Lats2 knockdown, or
expression of c-Abl mutants that escape inhibition by Lats2, enabled
DNA damage-induced apoptosis of densely plated cells, while Lats2
overexpression inhibited apoptosis in sparse cells. These findings
explain a long-standing enigma of why densely plated cells are
radioresistant. Furthermore, they demonstrate that the Hippo
pathway regulates cell fate decisions in response to DNA damage.
Similar content being viewed by others
[image]
Targeting the Hippo pathway in cancer
Article 30 June 2025
[image]
Hippo pathway regulation by phosphatidylinositol
transfer protein and phosphoinositides
Article 04 July 2022
[image]
Direct targeting of amplified gene loci for
proapoptotic anticancer therapy
Article 28 October 2021
Log in or create a free account to read this
content


Gain free access to this article, as well as selected content from this
journal and more on nature.com
 Access through your institution
or
 Sign in or create an account 
[image] Continue with Google 
[image] Continue with ORCiD 
Abbreviations
ASPP:
apoptosis-stimulating protein of p53
c-Abl (ABL1):
Abelson tyrosine protein kinase 1
Arg (ABL2):
Abl-related gene
EMT:
epithelial to mesenchymal transition
FACS:
fluorescence-activated cell sorting
Lats:
large tumor suppressor
Mdm:


mouse double minute
Mst:
mammalian STE20-like protein kinase
PARP:
poly ADP-ribose polymerase
RASSF:
RAS association domain family
Rb:
retinoblastoma
Taz:
transcription coactivator with PDZ-binding motif
WW45:
45 kDa WW domain protein
Yap:
Yes-associated protein
References
1. Vousden KH, Prives C . Blinded by the light: the growing
complexity of p53. Cell 2009; 137: 413–431.
Article  CAS  Google Scholar 
2. Beckerman R, Prives C . Transcriptional regulation by p53.
Cold Spring Harbor Perspect Biol 2010; 2: a000935.
Article  Google Scholar 


3. Bar J, Cohen-Noyman E, Geiger B, Oren M . Attenuation of
the p53 response to DNA damage by high cell density.
Oncogene 2004; 23: 2128–2137.
Article  CAS  Google Scholar 
4. Pan D . The hippo signaling pathway in development and
cancer. Dev Cell 2010; 19: 491–505.
Article  CAS  Google Scholar 
5. Pan D . Hippo signaling in organ size control. Genes Dev 2007;
21: 886–897.
Article  CAS  Google Scholar 
6. Zhao B, Li L, Lei Q, Guan KL . The Hippo-YAP pathway in
organ size control and tumorigenesis: an updated version.
Genes Dev 2010; 24: 862–874.
Article  CAS  Google Scholar 
7. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J et al. The role
of YAP transcription coactivator in regulating stem cell self-
renewal and differentiation. Genes Dev 2010; 24: 1106–1118.
Article  CAS  Google Scholar 
8. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A,
Frasson C et al. The Hippo transducer TAZ confers cancer
stem cell-related traits on breast cancer cells. Cell 2011; 147:
759–772.
Article  CAS  Google Scholar 
9. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J et al.
Inactivation of YAP oncoprotein by the Hippo pathway is
involved in cell contact inhibition and tissue growth control.
Genes Dev 2007; 21: 2747–2761.
Article  CAS  Google Scholar 


10. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH et al. TAZ
promotes cell proliferation and epithelial-mesenchymal
transition and is inhibited by the hippo pathway. Mol Cell Biol
2008; 28: 2426–2436.
Article  CAS  Google Scholar 
11. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL . A
coordinated phosphorylation by Lats and CK1 regulates YAP
stability through SCF(beta-TRCP). Genes Dev 2010; 24: 72–85.
Article  CAS  Google Scholar 
12. Zhang H, Liu CY, Zha ZY, Zhao B, Yao J, Zhao S et al. TEAD
transcription factors mediate the function of TAZ in cell
growth and epithelial-mesenchymal transition. J Biol Chem
2009; 284: 13355–13362.
Article  CAS  Google Scholar 
13. Wu S, Liu Y, Zheng Y, Dong J, Pan D . The TEAD/TEF family
protein Scalloped mediates transcriptional output of the
Hippo growth-regulatory pathway. Dev Cell 2008; 14: 388–
398.
Article  CAS  Google Scholar 
14. Zhao B, Ye X, Yu J, Li L, Li W, Li S et al. TEAD mediates YAP-
dependent gene induction and growth control. Genes Dev
2008; 22: 1962–1971.
Article  CAS  Google Scholar 
15. Ota M, Sasaki H . Mammalian Tead proteins regulate cell
proliferation and contact inhibition as transcriptional
mediators of Hippo signaling. Development 2008; 135: 4059–
4069.
Article  CAS  Google Scholar 
16. Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J . The
TEAD/TEF family of transcription factor Scalloped mediates


Hippo signaling in organ size control. Dev Cell 2008; 14: 377–
387.
Article  CAS  Google Scholar 
17. Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A
et al. Physical interaction with Yes-associated protein
enhances p73 transcriptional activity. J Biol Chem 2001; 276:
15164–15173.
Article  CAS  Google Scholar 
18. Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY et al.
p73 is regulated by tyrosine kinase c-Abl in the apoptotic
response to DNA damage. Nature 1999; 399: 814–817.
Article  CAS  Google Scholar 
19. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG Jr.,
Levrero M et al. The tyrosine kinase c-Abl regulates p73 in
apoptotic response to cisplatin-induced DNA damage. Nature
1999; 399: 806–809.
Article  CAS  Google Scholar 
20. Agami R, Blandino G, Oren M, Shaul Y . Interaction of c-Abl
and p73alpha and their collaboration to induce apoptosis.
Nature 1999; 399: 809–813.
Article  CAS  Google Scholar 
21. Levy D, Adamovich Y, Reuven N, Shaul Y . Yap1
phosphorylation by c-Abl is a critical step in selective
activation of proapoptotic genes in response to DNA damage.
Mol Cell 2008; 29: 350–361.
Article  CAS  Google Scholar 
22. Levy D, Reuven N, Shaul Y . A regulatory circuit controlling
Itch-mediated p73 degradation by Runx. J Biol Chem 2008;
283: 27462–27468.


Article  CAS  Google Scholar 
23. Radu M, Chernoff J . The DeMSTification of mammalian
Ste20 kinases. Curr Biol 2009; 19: R421–R425.
Article  CAS  Google Scholar 
24. Matallanas D, Romano D, Yee K, Meissl K, Kucerova L,
Piazzolla D et al. RASSF1A elicits apoptosis through an MST2
pathway directing proapoptotic transcription by the p73
tumor suppressor protein. Molecular cell 2007; 27: 962–975.
Article  CAS  Google Scholar 
25. Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X
et al. The Lats2 tumor suppressor augments p53-mediated
apoptosis by promoting the nuclear proapoptotic function of
ASPP1. Genes Dev 2010; 24: 2420–2429.
Article  CAS  Google Scholar 
26. Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL . Cell
detachment activates the Hippo pathway via cytoskeleton
reorganization to induce anoikis. Genes Dev 2012; 26: 54–68.
Article  Google Scholar 
27. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC
et al. Transforming properties of YAP, a candidate oncogene
on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA
2006; 103: 12405–12410.
Article  CAS  Google Scholar 
28. Hao Y, Chun A, Cheung K, Rashidi B, Yang X . Tumor
suppressor LATS1 is a negative regulator of oncogene YAP. J
Biol Chem 2008; 283: 5496–5509.
Article  CAS  Google Scholar 
29. Oka T, Mazack V, Sudol M . Mst2 and Lats kinases regulate
apoptotic function of Yes kinase-associated protein (YAP). J


Biol Chem 2008; 283: 27534–27546.
Article  CAS  Google Scholar 
30. Goldberg Z, Vogt Sionov R, Berger M, Zwang Y, Perets R, Van
Etten RA et al. Tyrosine phosphorylation of Mdm2 by c-Abl:
implications for p53 regulation. EMBO J 2002; 21: 3715–
3727.
Article  CAS  Google Scholar 
31. Zuckerman V, Lenos K, Popowicz GM, Silberman I, Grossman
T, Marine JC et al. c-Abl phosphorylates Hdmx and regulates
its interaction with p53. J Biol Chem 2009; 284: 4031–4039.
Article  CAS  Google Scholar 
32. Brasher BB, Van Etten RA . c-Abl has high intrinsic tyrosine
kinase activity that is stimulated by mutation of the Src
homology 3 domain and by autophosphorylation at two
distinct regulatory tyrosines. J Biol Chem 2000; 275: 35631–
35637.
Article  CAS  Google Scholar 
33. Pluk H, Dorey K, Superti-Furga G . Autoinhibition of c-Abl.
Cell 2002; 108: 247–259.
Article  CAS  Google Scholar 
34. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, Schreiber
SL . Structural basis for the binding of proline-rich peptides to
SH3 domains. Cell 1994; 76: 933–945.
Article  CAS  Google Scholar 
35. Crooks GE, Hon G, Chandonia JM, Brenner SE . WebLogo: a
sequence logo generator. Genome Res 2004; 14: 1188–1190.
Article  CAS  Google Scholar 
36. Brasher BB, Roumiantsev S, Van Etten RA . Mutational


analysis of the regulatory function of the c-Abl Src homology
3 domain. Oncogene 2001; 20: 7744–7752.
Article  CAS  Google Scholar 
37. Ben-Yehoyada M, Ben-Dor I, Shaul Y . c-Abl tyrosine kinase
selectively regulates p73 nuclear matrix association. J Biol
Chem 2003; 278: 34475–34482.
Article  CAS  Google Scholar 
38. Midgley CA, Owens B, Briscoe CV, Thomas DB, Lane DP, Hall
PA . Coupling between gamma irradiation, p53 induction and
the apoptotic response depends upon cell type in vivo. J Cell
Sci 1995; 108 Pt 5 1843–1848.
CAS  Google Scholar 
39. MacCallum DE, Hupp TR, Midgley CA, Stuart D, Campbell SJ,
Harper A et al. The p53 response to ionising radiation in adult
and developing murine tissues. Oncogene 1996; 13: 2575–
2587.
CAS  PubMed  Google Scholar 
40. Gottlieb E, Haffner R, King A, Asher G, Gruss P, Lonai P et al.
Transgenic mouse model for studying the transcriptional
activity of the p53 protein: age- and tissue-dependent changes
in radiation-induced activation during embryogenesis. EMBO
J 1997; 16: 1381–1390.
Article  CAS  Google Scholar 
41. Komarova EA, Chernov MV, Franks R, Wang K, Armin G,
Zelnick CR et al. Transgenic mice with p53-responsive lacZ:
p53 activity varies dramatically during normal development
and determines radiation and drug sensitivity in vivo. EMBO J
1997; 16: 1391–1400.
Article  CAS  Google Scholar 
42. Wilson JW, Pritchard DM, Hickman JA, Potten CS .


Radiation-induced p53 and p21WAF-1/CIP1 expression in the
murine intestinal epithelium: apoptosis and cell cycle arrest.
Am J Pathol 1998; 153: 899–909.
Article  CAS  Google Scholar 
43. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW,
Jaenisch R et al. YAP1 increases organ size and expands
undifferentiated progenitor cells. Curr Biol 2007; 17: 2054–
2060.
Article  CAS  Google Scholar 
44. Dick FA, Mymryk JS . Sweet DREAMs for Hippo. Genes Dev
2011; 25: 889–894.
Article  CAS  Google Scholar 
45. Nicolay BN, Bayarmagnai B, Islam AB, Lopez-Bigas N, Frolov
MV . Cooperation between dE2F1 and Yki/Sd defines a
distinct transcriptional program necessary to bypass cell cycle
exit. Genes Dev 2011; 25: 323–335.
Article  CAS  Google Scholar 
46. Tschop K, Conery AR, Litovchick L, Decaprio JA, Settleman J,
Harlow E et al. A kinase shRNA screen links LATS2 and the
pRB tumor suppressor. Genes Dev 2011; 25: 814–830.
Article  CAS  Google Scholar 
47. Litovchick L, Florens LA, Swanson SK, Washburn MP,
DeCaprio JA . DYRK1A protein kinase promotes quiescence
and senescence through DREAM complex assembly. Genes Dev
2011; 25: 801–813.
Article  CAS  Google Scholar 
48. Sirvent A, Benistant C, Roche S . Cytoplasmic signalling by
the c-Abl tyrosine kinase in normal and cancer cells. Biol Cell
2008; 100: 617–631.


Article  CAS  Google Scholar 
49. Colicelli J . ABL tyrosine kinases: evolution of function,
regulation, and specificity. Sci Signal 2010; 3: re6.
Article  Google Scholar 
50. Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast
AM . c-Abl is activated by growth factors and Src family
kinases and has a role in the cellular response to PDGF. Genes
Dev 1999; 13: 2400–2411.
Article  CAS  Google Scholar 
51. Srinivasan D, Sims JT, Plattner R . Aggressive breast cancer
cells are dependent on activated Abl kinases for proliferation,
anchorage-independent growth and survival. Oncogene 2008;
27: 1095–1105.
Article  CAS  Google Scholar 
52. Tanos B, Pendergast AM . Abl tyrosine kinase regulates
endocytosis of the epidermal growth factor receptor. J Biol
Chem 2006; 281: 32714–32723.
Article  CAS  Google Scholar 
53. Woodring PJ, Hunter T, Wang JY . Regulation of F-actin-
dependent processes by the Abl family of tyrosine kinases. J
Cell Sci 2003; 116 (Pt 13): 2613–2626.
Article  CAS  Google Scholar 
54. Sawyers CL . Chronic myeloid leukemia. New Engl J Med
1999; 340: 1330–1340.
Article  CAS  Google Scholar 
55. Levy D, Adamovich Y, Reuven N, Shaul Y . The Yes-associated
protein 1 stabilizes p73 by preventing Itch-mediated
ubiquitination of p73. Cell and Differentiation 2007; 14: 743–
751.


Article  CAS  Google Scholar 
56. Okada N, Yabuta N, Suzuki H, Aylon Y, Oren M, Nojima H . A
novel Chk1/2-Lats2-14-3-3 signaling pathway regulates P-
body formation in response to UV damage. J Cell Sci 2011;
124 (Pt 1): 57–67.
Article  CAS  Google Scholar 
Download references
Acknowledgements
We thank M Oren and Y Aylon for helpful discussion and for the
myc-Lats2 constructs and reagents. We thank XJ Yang for the HA-
Lats2, Mst1 and WW45 constructs. We thank G Superti-Furga for
the pSLX c-Abl constructs. STI571 was kindly provided by Novartis
Pharmaceuticals. We thank R Keshet for providing the pBabe Flag-
Yap constructs, and M Elbaz for her technical assistance. This work
was supported by grants from the Israel Science Foundation (grant
no. 551/11), Israel Cancer Research Fund, the Cooperation Program
in Cancer Research of the Deutsches Krebsforschungszentrum
(DKFZ) and Israel’s Ministry of Science and Technology (MOST) and
from the Minerva Foundation with funding from the Federal
German Ministry for Education and Research.
Author information
Authors and Affiliations
1. Department of Molecular Genetics, Weizmann Institute of
Science, Rehovot, Israel
N Reuven, J Adler, V Meltser & Y Shaul
Authors
1. N Reuven


View author publications
Search author on:PubMed Google Scholar
2. J Adler
View author publications
Search author on:PubMed Google Scholar
3. V Meltser
View author publications
Search author on:PubMed Google Scholar
4. Y Shaul
View author publications
Search author on:PubMed Google Scholar
Corresponding author
Correspondence to Y Shaul.
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by B Zhivotovsky
Supplementary Information accompanies this paper on Cell Death
and Differentiation website
Supplementary information


Supplementary Figure 1 (PDF 448 kb)
Supplementary Figure 2 (PDF 88 kb)
Supplementary Figure 3 (PDF 600 kb)
Supplementary Figure 4 (PDF 190 kb)
Supplementary Figure 5 (PDF 390 kb)
Supplementary Figure 6 (PDF 147 kb)
Supplementary Figure Legends (DOC 71 kb)
Rights and permissions
Reprints and permissions
About this article
Cite this article
Reuven, N., Adler, J., Meltser, V. et al. The Hippo pathway kinase
Lats2 prevents DNA damage-induced apoptosis through inhibition
of the tyrosine kinase c-Abl. Cell Death Differ 20, 1330–1340 (2013).
https://doi.org/10.1038/cdd.2013.83
Download citation
•  Received: 21 February 2013
•  Revised: 13 May 2013
•  Accepted: 27 May 2013


•  Published: 12 July 2013
•  Issue date: October 2013
•  DOI: https://doi.org/10.1038/cdd.2013.83
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
Keywords
•  DNA damage response
•  high cell density
•  Hippo pathway
•  c-Abl inhibition
•  radioresistant
This article is cited by
•  Inhibition of LATS kinases reduces
tumorigenicity and increases the sensitivity of
human chronic myelogenous leukemia cells to
imatinib
○  Phatchanat Klaihmon
○  Chanchao Lorthongpanich
○  Surapol Issaragrisil


Scientific Reports (2024)
•  Carcinogenesis promotion in oral squamous cell
carcinoma: KDM4A complex-mediated gene
transcriptional suppression by LEF1
○  Yiming Hou
○  Wenqian Yu
○  Lei Chen
Cell Death & Disease (2023)
•  Hippo pathway dysregulation in gastric cancer:
from Helicobacter pylori infection to tumor
promotion and progression
○  Beatrice Messina
○  Federica Lo Sardo
○  Giulia Bon
Cell Death & Disease (2023)
•  Live-cell imaging and mathematical analysis of
the “community effect” in apoptosis
○  Diane Coursier
○  David Coulette
○  Gabriel Ichim
Apoptosis (2023)
•  SMG6 regulates DNA damage and cell survival in
Hippo pathway kinase LATS2-inactivated
malignant mesothelioma
○  Koya Suzuki
○  Masaki Tange
○  Yuko Murakami-Tonami


Cell Death Discovery (2022)
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Videos
•  Current issue
•  Collections
•  Follow us on Twitter
•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Journal Information
•  About the Editors
•  Open access publishing
•  About the Partner
•  Contact
•  Special Issues
•  For Advertisers
•  Subscribe
•  Upcoming Conferences
Publish with us


•  For Authors & Referees
•  Language editing services
•  Open access funding
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Cell Death & Differentiation (Cell Death Differ)
ISSN 1476-5403 (online)
ISSN 1350-9047 (print)
nature.com sitemap
About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z


•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services
•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites


•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


[image]


